aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed Mar 20, 2018 · 10-K · 79 days after period end · 0001564590-18-006333
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Net Income | -$11.47M | -$12.57M | -$16.49M | -$6.04M |
| EPS Diluted | -$0.39 | -$0.53 | -$0.70 | -$7.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 20, 2018 · 79 d after period end
